Physician Assistant in Dobson, NC Accepting Medicare
3 Physician Assistant nurses found. Showing 1 - 3
 Hannah Grace Beasley, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 911 E Atkins St, Dobson, NC 27017 Phone: 336-374-1010 |
 Mr. Ricky J Vernon, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 118 Hamby Street, Dobson, NC 27017 Phone: 336-401-8548 |
Ms. Elizabeth Anne Mcgurk, PA-C, MPH Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 118 Hamby Rd, Dobson, NC 27017 Phone: 336-401-8410 |
News Archive
Pfizer presents data on in vivo activity of PF-04523655 siRNA drug candidate at ARVO annual meeting
Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today that researchers from Pfizer, Inc. presented data on in vivo activity of PF-04523655 at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, being held May 2-6, 2010 in Fort Lauderdale.
Study finds AFREZZA comparable to standard of care insulin therapy
Pulmonary function test results (PFTs) in patients treated with AFREZZATM (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, ultra rapid acting insulin, at follow-up measurements were similar to PFT results observed in patients receiving standard antidiabetic therapy, according to data presented today at the American Association of Clinical Endocrinologists 19th Annual Meeting (Poster #267).
New findings have implications for chronic use of COX-2 Inhibitors in pre-menopausal women
Heart disease is less pronounced in women than in men as humans age, but this difference narrows after menopause. Some studies have shown that estrogen slows heart disease in mouse models, but the mechanism is largely unknown.
Gastroenterology journal publishes results of Lexicon LX1031 Phase 2 trial in IBS
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that results from the Phase 2 clinical trial of LX1031 in patients with non-constipating irritable bowel syndrome (IBS) were published earlier this week in the August 2011 edition of the journal Gastroenterology.
› Verified 5 days ago